The Alliance for Regenerative Medicine: Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan
ATMPs are uniquely positioned to attack cancer at its source, bringing life-changing benefits to patients
BRUSSELS, BELGIUM - February 3, 2021
The Alliance for Regenerative Medicine (ARM) the global voice of the regenerative medicine and advanced therapies sector applauds the EU Beating Cancer Plan s identification of Advanced Therapy Medicinal Products (ATMPs) as part of a comprehensive cancer solution. ATMPs include cell and gene therapies that have already revolutionized the treatment of some aggressive forms of blood cancers and hold great promise for addressing other types of cancer.